Mangafodipir

In the US, Mangafodipir (mangafodipir systemic) is a member of the drug class magnetic resonance imaging contrast media.

US matches:

• Mangafodipir Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

V08CA05

CAS registry number (Chemical Abstracts Service)

0155319-91-8

Chemical Formula

C22-H30-Mn-N4-O14-P2

Molecular Weight

691

Therapeutic Category

Diagnostic agent

Chemical Name

Hexahydrogen (OC-6-13)-[[N,N'-ethylenebis[N-[[3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl]methyl]glycine] 5,5'-bis-(phosphato)](8-)]manganate(6-) (WHO)

Foreign Names

• Mangafodipirum (Latin)
• Mangafodipir (German)
• Mangafodipir (French)
• Mangafodipir (Spanish)

Generic Names

• Mangafodipir (OS: BAN)
• MnDPDP (IS)
• S 095 (IS)
• Mangafodipir Trisodium (OS: BANM, USAN)
• Win 59010-2 (IS)
• Mangafodipir trisodium (PH: USP 32)

Brand Names

• Teslascan
  Amersham, Bulgaria; Amersham, Spain; Amersham, Hungary; Amersham, Norway; GE Healthcare, Belgium; GE Healthcare, Switzerland; GE Healthcare, Czech Republic; GE Healthcare, Germany; GE Healthcare, France; GE Healthcare, Italy; GE Healthcare, Luxembourg; GE Healthcare, Sweden; GE Healthcare AS, Austria; Nycomed, Greece; Nycomed, Slovenia

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.